Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen

Published:2016-11-24 Issue:52 Volume:55 Page:16115-16118
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Ota Yosuke¹,Itoh Yukihiro¹,Kaise Asako²,Ohta Kiminori²,Endo Yasuyuki²,Masuda Mitsuharu¹,Sowa Yoshihiro¹,Sakai Toshiyuki¹,Suzuki Takayoshi¹³

Affiliation:

1. Graduate School of Medical Science; Kyoto Prefectural University of Medicine; 1-5 Shimogamohangi-Cho Sakyo-Ku Kyoto 606-0823 Japan

2. Faculty of Pharmaceutical Sciences; Tohoku Medical and Pharmaceutical University; 4-4-1 Komatsushima Aoba-ku Sendai 981-8558 Japan

3. CREST Japan Science and Technology Agency (JST); 4-1-8 Honcho Kawaguchi Saitama 332-0012 Japan

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference33 articles.

1. Chemotherapy and the war on cancer

2. A History of Cancer Chemotherapy

3. Strategies in the design of nanoparticles for therapeutic applications

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting LSD1 in cancer: Molecular elucidation and recent advances;Cancer Letters;2024-08

2. Research progress of LSD1-based dual-target agents for cancer therapy;Bioorganic & Medicinal Chemistry;2024-03

3. Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells;Bioorganic & Medicinal Chemistry;2024-02

4. Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy;Journal of Medicinal Chemistry;2024-01-12

5. LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study;Molecules;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3